Keyphrases
Intimal Hyperplasia
100%
Vein Graft
100%
Recombinant
100%
Local Treatment
100%
Tissue Factor Pathway inhibitor-2 (TFPI-2)
100%
Human Tissue
90%
Recombinant Human
90%
Inhibitor Treatment
36%
Tissue Factor
27%
Placebo
18%
Incubation
18%
Western Analysis
18%
Beneficial Effects
9%
CD18
9%
Carotid Artery
9%
Jugular Vein
9%
Vein Graft Failure
9%
Therapeutic Potential
9%
Immunohistochemical Analysis
9%
New Zealand White Rabbit
9%
Bypass Grafting
9%
Intimal Thickness
9%
Local Administration
9%
Leukocytes
9%
Arterial Injury
9%
Thrombin Generation
9%
New Therapeutics
9%
Gel Treatment
9%
Tissue Factor Expression
9%
Vehicle Control
9%
Medicine and Dentistry
Vein Graft
100%
Human Tissue
100%
Intimal Hyperplasia
100%
Local Therapy
100%
Tissue Factor Pathway Inhibitor
100%
Recombinant Tissue Factor Pathway Inhibitor
100%
Thromboplastin
40%
Ex Vivo
30%
Placebo
20%
Incubation
20%
Leukocyte
10%
Carotid Artery
10%
Graft Failure
10%
Jugular Vein
10%
Thrombin
10%
Artery Injury
10%
Grafting
10%